Primary prevention of ROP and the oxygen saturation targeting trials

被引:14
|
作者
Darlow, Brian A. [1 ]
Husain, Shahid [2 ]
机构
[1] Univ Otago, Paediat, Christchurch, New Zealand
[2] Homerton Univ Hosp, Neonatal Med, London, England
关键词
Retinopathy of prematurity; Very preterm infants; Oxygen saturation targeting; Middle-income countries; Prevention of morbidity; Randomised controlled trials; NEONATAL INTENSIVE-CARE; AGGRESSIVE POSTERIOR RETINOPATHY; GESTATIONAL-AGE; PRETERM INFANTS; PULSE OXIMETRY; ONSET SEPSIS; PREMATURITY; BIRTH; ASSOCIATION; MORTALITY;
D O I
10.1053/j.semperi.2019.05.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Reducing the burden of visual morbidity from retinopathy of prematurity (ROP) begins with primary prevention, and improvements in neonatal care with a positive impact on ROP are possible in all settings. Strategies range from rigorous adoption of inexpensive evidence-based protocols, for example on temperature control, prevention of sepsis and support for breast-milk feeding, through to comprehensive quality improvement programmes, and fostering team work and camaraderie. Oxygen monitoring is essential for very preterm infants receiving supplementary oxygen. The Neonatal Oxygenation Prospective Meta-analysis (NeOProM) collaboration has reported analysis of five trials of oxygen saturation (SpO(2)) targeting in very preterm infants and shown that a SpO(2) target of 85-89% compared to 91-95% was associated with increased mortality (on average 28 extra deaths for every 1000 infants treated). Adopting a SpO(2) target higher than 85-89% might increase the risk of ROP for some infants, highlighting the importance of pursuing all other means of prevention. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 50 条
  • [21] Compliance in oxygen saturation targeting in preterm infants: a systematic review
    Henriëtte A. van Zanten
    Ratna N. G. B. Tan
    Agnes van den Hoogen
    Enrico Lopriore
    Arjan B. te Pas
    European Journal of Pediatrics, 2015, 174 : 1561 - 1572
  • [22] Prevention of ROP Blindness Preface
    Quinn, Graham E.
    Fielder, Alistair R.
    CLINICS IN PERINATOLOGY, 2013, 40 (02) : XVII - XVIII
  • [23] MULTI-FACTOR PRIMARY PREVENTION TRIALS
    ROSE, G
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 : 20 - &
  • [24] Status of primary prevention trials in Alzheimer disease
    Thal, L
    NEUROBIOLOGY OF AGING, 2006, 27 : S21 - S21
  • [25] Follow-up on primary prevention trials
    Marais, AD
    CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (06) : 551 - 556
  • [26] Primary Prevention of CVD The Role of Imaging Trials
    Rozanski, Alan
    Muhlestein, Joseph B.
    Berman, Daniel S.
    JACC-CARDIOVASCULAR IMAGING, 2017, 10 (03) : 304 - 317
  • [27] Recruitment for fracture prevention trials in primary care
    Porthouse, J
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 116S - 116S
  • [28] Methodological issues in the design of primary prevention trials
    Gaziano, JM
    Hennekens, CH
    Buring, JE
    CHEMOPREVENTION IN CANCER CONTROL, 1996, (136): : 7 - 12
  • [29] Challenges of Designing Trials for the Primary Prevention of Stroke
    Gorelick, Philip B.
    STROKE, 2009, 40 (03) : S82 - S84
  • [30] Recruitment for fracture prevention trials in primary care
    Porthouse, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S24 - S24